CIS-DIAMMINEDICHLOROPLATINUM(II) THERAPY FOR ADVANCED OVARIAN-CANCER

被引：0
|
作者：
PESANDO, JM
COME, SE
STARK, J
PARKER, LM
GRIFFITHS, CT
CANELLOS, GP
机构：
[1] SIDNEY FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA
[2] SIDNEY FARBER CANC INST, DIV MED ONCOL, BOSTON, MA 02115 USA
[3] BETH ISRAEL HOSP, BOSTON, MA 02215 USA
[4] BOSTON HOSP WOMEN, BOSTON, MA 02115 USA
[5] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
来源：
CANCER TREATMENT REPORTS | 1980年 / 64卷 / 10-1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1147 / 1148
页数：2
相关论文
共 50 条
  • [21] INCREASED REMOVAL OF DNA-BOUND PLATINUM IN A HUMAN OVARIAN-CANCER CELL-LINE RESISTANT TO CIS-DIAMMINEDICHLOROPLATINUM(II)
    MASUDA, H
    TANAKA, T
    MATSUDA, H
    KUSABA, I
    CANCER RESEARCH, 1990, 50 (06) : 1863 - 1866
  • [22] CIS-DIAMMINEDICHLOROPLATINUM (II) - 2ND LINE INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN ADENOCARCINOMA
    PIVER, MS
    BARLOW, JJ
    LELE, SB
    MALFETANO, JH
    MCPHEE, ME
    JOURNAL OF SURGICAL ONCOLOGY, 1983, 24 (04) : 329 - 331
  • [23] CLINICAL EVALUATION OF CIS-DIAMMINEDICHLOROPLATINUM (DDP) IN TREATMENT OF ADVANCED CANCER
    WALLACE, HJ
    HIGBY, DJ
    HENDERSO.ES
    BEKESI, JG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1974, : 20 - 20
  • [24] EFFECT OF CIS-DIAMMINEDICHLOROPLATINUM(II) AND ADRIAMYCIN COMBINATION ON OVARIAN-CARCINOMA
    MISAWA, T
    KIKKAWA, F
    MAEDA, O
    OGUCHI, H
    KOJIMA, M
    KAWAI, M
    HIGASHIDE, K
    SUGANUMA, N
    TOMODA, Y
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1994, 13 (01) : 49 - 55
  • [25] RENAL HANDLING OF CIS-DIAMMINEDICHLOROPLATINUM(II)
    JACOBS, C
    KALMAN, SM
    TRETTON, M
    WEINER, MW
    CANCER TREATMENT REPORTS, 1980, 64 (12): : 1223 - 1226
  • [26] BINDING FOR CIS-DIAMMINEDICHLOROPLATINUM(II) TO DINUCLEOTIDES
    FORSTI, A
    LAATIKAINEN, R
    HEMMINKI, K
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1750 - 1750
  • [27] INCREASED DNA-REPAIR AS A MECHANISM OF ACQUIRED-RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM(II) IN HUMAN OVARIAN-CANCER CELL-LINES
    MASUDA, H
    OZOLS, RF
    LAI, GM
    FOJO, A
    ROTHENBERG, M
    HAMILTON, TC
    CANCER RESEARCH, 1988, 48 (20) : 5713 - 5716
  • [28] ABROGATION OF SUPPRESSOR CELLS ACTIVITY BY CIS-DIAMMINEDICHLOROPLATINUM (CDDP) TREATMENT USING THERAPEUTIC DOSES IN OVARIAN-CANCER PATIENTS
    TSUDA, H
    KITAHASHI, S
    UMESAKI, N
    KANAOKA, Y
    KAWABATA, M
    OGITA, S
    GYNECOLOGIC ONCOLOGY, 1994, 52 (02) : 218 - 221
  • [29] CIS-DICHLORODIAMMINEPLATINUM(II) FOR THE TREATMENT OF ADVANCED OVARIAN-CANCER
    YOUNG, RC
    VONHOFF, DD
    GORMLEY, P
    MAKUCH, R
    CASSIDY, J
    HOWSER, D
    BULL, JM
    CANCER TREATMENT REPORTS, 1979, 63 (9-10): : 1539 - 1544
  • [30] CIS-DIAMMINEDICHLOROPLATINUM(II) (CDDP) (NSC-119875) AND ADRIAMYCIN (ADM) (NSC-123127) TREATMENT OF ADVANCED OVARIAN CANCER
    BRISCOE, K
    PASMANTIER, M
    BROWN, J
    KENNEDY, BJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 378 - 378
12345